Trials / Completed
CompletedNCT00723775
GSK706769/KALETRA Drug-drug Interaction Study
Phase I, Open Label Drug-drug Interaction Study in Healthy Volunteers to Evaluate the Effect of KALETRA (Lopinavir-ritonavir) on GSK706769 Pharmacokinetics and to Evaluate the Pharmacokinetics of a New Oral Formulation of GSK706769
- Status
- Completed
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 17 (actual)
- Sponsor
- GlaxoSmithKline · Industry
- Sex
- All
- Age
- 18 Years – 50 Years
- Healthy volunteers
- Accepted
Summary
To compare plasma GSK706769 PK following repeat administration of GSK706769 QD with and without KALETRA (LPV 400 mg/RTV 100mg) q12h
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | GSK706769 & KALETRA | GSK706769 alone and GSK706769 + Kaletra |
Timeline
- Start date
- 2008-07-24
- Primary completion
- 2008-11-08
- Completion
- 2008-11-08
- First posted
- 2008-07-29
- Last updated
- 2017-07-21
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT00723775. Inclusion in this directory is not an endorsement.